ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Now I have good data on stocks with the most analyst changes and highest upside potential. Let me write the article focusing on the key patterns I see:

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Now I have good data on stocks with the most analyst changes and highest upside potential. Let me write the article focusing on the key patterns I see:

Analysts Swarm Chips and Pharma

MU Micron grabbed 6 analyst rating changes this week. The $403B memory giant showed 47.7% target upside per consensus. Chip equipment names drew fresh conviction as AI infrastructure demand persisted.

ARM Arm Holdings absorbed 5 rating revisions showing 14.3% upside potential. The $153B semiconductor designer climbed 31.9% year to date. Analysts maintained buy-heavy positioning despite momentum.

CoreWeave topped all stocks with 6 analyst changes. The $39B cloud infrastructure provider showed 59.6% upside. The AI compute play drew Wall Street attention following strong IPO debut.

Light & Wonder saw 5 rating shifts today. The $7.5B gaming tech name held 13% target upside. Analysts reassessed positioning as digital gambling momentum accelerated.

Pharma drew mixed conviction. Terns Pharmaceuticals logged 5 changes with 3.2% upside signaling modest confidence. Sutro Biopharma grabbed 5 revisions showing 14.1% potential as the biotech surged 111% year to date.

HOOD Robinhood absorbed 5 analyst updates. The $59B trading platform showed 80.4% upside despite dropping 41.6% this year. Wall Street split on fintech recovery timing amid market volatility.

Semiconductor and biotech names dominated analyst activity as firms repositioned around AI infrastructure and clinical trial catalysts.

How this article was generated

Generated
31 Mar 2026, 00:22
Prompt version
migrated
Data sources
Analyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.